Predictors of metformin monotherapy failure in gestational diabetes mellitus.
Vânia Benido SilvaLiliana FonsecaMaria Teresa PereiraJoana VilaverdeClara PintoFernando PichelMaria do Céu AlmeidaJorge DoresPublished in: Endocrine connections (2022)
In 685 (23.7%) women, combined therapy with insulin to reach glycemic control was required. Higher pre-gestational BMI, fasting PG levels in OGTT ≥87 mg/dL and introduction of metformin ≤29 weeks of GA were independent predictive factors for metformin monotherapy failure. The early recognition of these characteristics can contribute to the establishment of individualized therapeutic strategies and attain better metabolic control during pregnancy.